Introduction
During the initial stages of the COVID-19 pandemic, global data from the US, UK, and China highlighted the virus's severity. However, Canadian-specific data—particularly for patients managed outside of intensive care units—remained limited. To effectively manage hospital resources and communicate public health risks, it was essential to compare COVID-19 against a familiar clinical benchmark: seasonal influenza. This study provides a detailed characterization of COVID-19 hospitalizations across seven major hospitals in Toronto and Mississauga, Ontario, during the pandemic's first wave.
Methodology and Data Sources
The researchers conducted a retrospective cohort study utilizing the GEMINI hospital research collaborative platform. This platform aggregates high-quality administrative and clinical data, including laboratory results and vital signs, from hospital information systems. This data was cross-referenced with the Canadian Institute for Health Information (CIHI) databases, specifically the Discharge Abstract Database (DAD) and the National Ambulatory Care Reporting System (NACRS).
The study analyzed 43,462 total discharges (representing 34,782 unique patients) between November 1, 2019, and June 30, 2020. To isolate the impact of COVID-19, the team employed multivariable regression models to adjust for key confounders, including:
- Age and sex
- Charlson Comorbidity Index (pre-existing health conditions)
- Residence in long-term care (LTC)
- The specific admitting hospital
Key Findings: COVID-19 vs. Influenza
The study's primary insight is that COVID-19 is significantly more severe than seasonal influenza across all measured clinical outcomes, debunking early comparisons that suggested the two were similar in impact.
Mortality and ICU Resource Use
Even after adjusting for age and pre-existing conditions, COVID-19 patients faced a much higher risk of death. The unadjusted mortality rate for COVID-19 was 19.9%, compared to 6.1% for influenza. The adjusted Relative Risk (aRR) for in-hospital mortality was 3.47 (95% CI: 2.57, 4.67).
Furthermore, COVID-19 patients required more intensive resources. Approximately 26.4% of COVID-19 patients were admitted to the ICU, compared to 18.0% of influenza patients (aRR 1.52). The median hospital length-of-stay (LOS) for COVID-19 was 8.7 days, nearly double the 4.8 days observed for influenza.
Patient Demographics and Clinical Characteristics
The data challenged several early assumptions about the virus's target populations:
- The "Healthy" Population: Surprisingly, 54% of hospitalized COVID-19 patients had a Charlson comorbidity score of zero, indicating no major pre-existing chronic conditions were recorded in their charts.
- Impact on Younger Adults: Patients under the age of 50 accounted for 21.2% of all COVID-19 admissions and 24.0% of ICU admissions. Within this younger cohort, nearly 30% required ICU care, demonstrating that the virus posed a significant threat beyond the elderly population.
- Antibiotic Utilization: Despite the viral nature of COVID-19, over 70% of patients received respiratory-acting antibiotics. This likely reflects the clinical uncertainty during the first wave but highlights concerns regarding future antimicrobial resistance.
Discussion and Limitations
This study captures a specific window of the pandemic (the "first wave") before the widespread availability of vaccines or the standardized use of therapeutics like dexamethasone.
A notable limitation is the absence of socio-economic data, such as race, ethnicity, and income, which are known drivers of COVID-19 disparities. Additionally, the study's focus on large academic and community-based teaching hospitals may introduce a "transfer bias," as these centers often receive the most critically ill patients from other regions.
Conclusion
The findings underscore the substantial burden COVID-19 placed on the Canadian healthcare system during its initial emergence. By demonstrating that COVID-19 was associated with a 3.5-fold higher risk of death and significantly greater resource utilization than influenza, this research provided a critical evidence base for hospital capacity planning and public health interventions in Canada.
Summary updated